A Chemokine Receptor, CXCR4, Which Is Regulated by Hypoxia-Inducible Factor 2α, Is Crucial for Functional Endothelial Progenitor Cells Migration to Ischemic Tissue and Wound Repair

Stem Cells and Development

Volumn 25, Issue 3, 2016, Pages 266-276

  Tu, Tran Cam ^a   Nagano, Masumi ^a   Yamashita, Toshiharu ^a   Hamada, Hiromi ^a   Ohneda, Kinuko ^b   Kimura, Kenichi ^a   Ohneda, Osamu ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 2ALPHA; SHORT HAIRPIN RNA; VASCULOTROPIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; PROTEIN BINDING; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; ISCHEMIA; MEMBRANE MICROPARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN FLAP; STEM CELL CULTURE; WOUND HEALING; ANIMAL; C57BL MOUSE; CELL MOTION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; SKIN; VASCULARIZATION;

ALDEHYDE DEHYDROGENASE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL MOVEMENT; CHEMOKINE CXCL12; ENDOTHELIAL PROGENITOR CELLS; HUMANS; ISCHEMIA; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, CXCR4; SKIN; WOUND HEALING;

EID: 84955506665     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2015.0290     Document Type: Article

References (25)

1. Hill JM, G Zalos, JP Halcox, WH Schenke, MA Waclawiw, AA Quyyumi and T Finkel. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600.
2. Tepper OM, JM Capla, RD Galiano, DJ Ceradini, MJ Callaghan, ME Kleinman and GC Gurtner. (2005). Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 105:1068-1077.
3. Timmermans F, J Plum, MC Yoder, DA Ingram, B Vandekerckhove and J Case. (2009). Endothelial progenitor cells: identity defined? J Cell Mol Med 13:87-102.
4. Jiang M, B Wang, C Wang, B He, H Fan, TB Guo, Q Shao, L Gao and Y Liu. (2008). Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs. J Cell Biochem 103:321-334.
5. Asahara T and A Kawamoto. (2004). Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287:572-579.
6. Ceradini DJ, AR Kulkarni, MJ Callaghan, OM Tepper, N Bastidas, ME Kleinman, JM Capla, RD Galiano, JP Levine and GC Gurtner. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864.
7. Pesce M, A Orlandi, MG Iachininoto, S Straino, AR Torella, V Rizzuti, G Pompilio, G Bonanno, G Scambia and MC Capogrossi. (2003). Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res 93:e51-e62.
8. Alev C, M Ii and T Asahara. (2011). Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases. Antioxid Redox Signal 15:949-965.
9. Ratajczak J, M Wysoczynski, F Hayek, A Janowska-Wieczorek and MZ Ratajczak. (2006). Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:1487-1495.
10. Deregibus MC, V Cantaluppi, R Calogero, ML Iacono, C Tetta, L Biancone, S Bruno, B Bussolati and G Camussi. (2007). Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110:2440-2448.
11. Gu S, W Zhang, J Chen, R Ma, X Xiao, X Ma, Z Yao and Y Chen. (2014). EPC-derived microvesicles protect cardiomyocytes from Ang II-induced hypertrophy and apoptosis. PLoS One 9:e85396.
12. Nagano M, T Yamashita, H Hamada, K Ohneda, K Kimura, T Nakagawa, M Shibuya, H Yoshikawa and O Ohneda. (2007). Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood. Blood 110:151-160.
13. Critser PJ, ST Kreger, SL Voytik-Harbin and MC Yoder. (2010). Collagen matrix physical properties modulate endothelial colony forming cell-derived vessels in vivo. Microvasc Res 80:23-30.
14. Morita M, O Ohneda, T Yamashita, S Takahashi, N Suzuki, O Nakajima, S Kawauchi, M Ema, S Shibahara, et al. (2003). HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 22:1134-1146.
15. Bruno S, C Grange, MC Deregibus, RA Calogero, S Saviozzi, F Collino, L Morando, A Busca, M Falda, et al. (2009). Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067.
16. Li L, D Zhu, L Huang, J Zhang, Z Bian, X Chen, Y Liu, CY Zhang and K Zen. (2012). Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS One 7:e46957.
17. Ingram DA, LE Mead, H Tanaka, V Meade, A Fenoglio, K Mortell, K Pollok, MJ Ferkowicz, D Gilley and MC Yoder. (2004). Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752-2760.
18. Ranghino A, V Cantaluppi, C Grange, L Vitillo, F Fop, L Biancone, MC Deregibus, C Tetta, GP Segoloni and G Camussi. (2012). Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int J Immunopathol Pharmacol 25:75-85.
19. Cantaluppi V, S Gatti, D Medica, F Figliolini, S Bruno, MC Deregibus, A Sordi, L Biancone, C Tetta and G Camussi. (2012). Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int 82:412-427.
20. Würdinger T, BA Tannous, O Saydam, J Skog, S Grau, J Soutschek, R Weissleder, XO Breakefield and AM Krichevsky. (2008). miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14:382-393.
21. Wang S, AB Aurora, BA Johnson, X Qi, J McAnally, JA Hill, JA Richardson, R Bassel-Duby and EN Olson. (2008). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15:261-271.
22. Hoenig MR, C Bianchi, A Rosenzweig and FW Sellke. (2008). Decreased vascular repair and neovascularization with ageing: mechanisms and clinical relevance with an emphasis on hypoxia-inducible factor-1. Curr Mol Med 8:754-767.
23. Ohneda O, M Nagano and Y Fujii-Kuriyama. (2007). Role of hypoxia-inducible factor-2alpha in endothelial development and hematopoiesis. Methods Enzymol 435:199-218.
24. Ryan HE, J Lo and RS Johnson. (1998). HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17:3005-3015.
25. Kimura K, M Nagano, G Salazar, T Yamashita, I Tsuboi, H Mishima, S Matsushita, F Sato, K Yamagata and O Ohneda. (2014). The role of CCL5 in the ability of adipose tissue-derived mesenchymal stem cells to support repair of ischemic regions. Stem Cells Dev 23:488-501.